Beta Drugs (BETA) Share Price Rises 8.42% to Rs 2,097.00 Today

Beta Drugs Share Price stood at Rs 2,097.00 as of 12:37 PM IST on 28 October 2026, a gain of Rs 162.80 or 8.42% over the previous close of Rs 1,934.20. Beta Drugs Ltd. (BETA) has a market capitalisation of Rs 2,199.67 crore and belongs to the Healthcare sector, so this Beta Drugs Share Price rise places the stock among the Stocks Rising Today.

Univest data confirms the move itself, though no company-specific trigger has been identified. The stock opened at Rs 1,955.00, touched a low of Rs 1,903.80 and reached a high of Rs 2,097.00, which is the level it was trading at when this Beta Drugs Stock News update was prepared.

Beta Drugs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,097
Previous Close	Rs 1,934.2
Today's Move	Rs 162.8 (+8.42%)
Open	Rs 1,955
High	Rs 2,097
Low	Rs 1,903.8
Market Capitalisation	Rs 2,199.67 crore
Market Cap Category	Small Cap

Beta Drugs Ltd. (BETA) rose to Rs 2,097 from the previous close of Rs 1,934.2, a move of Rs 162.8 or 8.42%. The stock opened at Rs 1,955, reached a high of Rs 2,097, recorded a low of Rs 1,903.8.

Beta Drugs Share Price Today is Rs 2,097.00, up Rs 162.80 or 8.42% from the previous close of Rs 1,934.20. The stock opened at Rs 1,955.00, dipped to a low of Rs 1,903.80 and then moved to a high of Rs 2,097.00, matching its current level.

The opening print was Rs 20.80 above the previous close, so the stock began the session with a gap up. Soon after, Beta Drugs Share Price dipped Rs 30.40 below the previous close at the day low of Rs 1,903.80, before reversing and rising through the rest of the morning.

The gap between the day low and the day high is Rs 193.20, a wide intraday range for Beta Drugs Share Price. That range is the clearest sign of how active the Beta Drugs Share Price Rise has been so far today. With a market capitalisation of Rs 2,199.67 crore, the company is a compact name in the Pharmaceuticals and Drugs industry.

This Beta Drugs Share Price snapshot is a live reading and can change with every trade. The Beta Drugs Share Price Update continues with a look at whether the fundamentals explain the attention.

Beta Drugs Ltd. (BETA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,199.67 crore
P/E Ratio	41.43x
P/B Ratio	4.91x
ROE	18.78%
ROCE	19.16%
EPS	Rs 46.68
Book Value Per Share	Rs 393.57
Dividend Yield	0%

Beta Drugs Ltd. (BETA) fundamental metrics show P/E 41.43x, P/B 4.91x, ROE 18.78%, ROCE 19.16%. Read together, these ratios describe the company's position rather than a recommendation.

Beta Drugs Ltd. has a market capitalisation of Rs 2,199.67 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.43x, P/B at 4.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 46.68, book value per share of Rs 393.57, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.74x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	41.43x
Benchmark Median P/E	30.74x
Benchmark Average P/E	43.3x
Benchmark P/E Range	3.21x to 577.05x
Company P/B Ratio	4.91x
Benchmark Median P/B	2.71x
Company ROE	18.78%
Benchmark Median ROE	11.23%
Company ROCE	19.16%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 2,199.67 crore
Benchmark Median Market Cap	Rs 696.43 crore

Beta Drugs Ltd. (BETA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Beta Drugs Ltd. (BETA) has a P/E ratio of 41.43x, which is above the benchmark median of 30.74x, a difference of +34.78%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Beta Drugs Ltd. (BETA) has a ROE of 18.78%, which is above the benchmark median of 11.23%, a difference of +67.23%. Beta Drugs Ltd. (BETA) has a ROCE of 19.16%, which is above the benchmark median of 13.17%, a difference of +45.48%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,18,204.09	34.91	4.88	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,40,780	86.02	14.25	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,73,828.11	82.48	9.53	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,520.92	25.79	4.32	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,11,304.32	105.74	20.5	18.31	18.2

Beta Drugs Ltd. (BETA) has a P/E ratio of 41.43x compared with the displayed peer median of 82.48x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 18.78% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 19.16% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Beta Drugs Ltd. (BETA) has a market capitalisation of Rs 2,199.67 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Beta Drugs

Three verified points explain the attention on Beta Drugs Share Price today: the size of the price move, the level of its fundamentals and its position against the industry benchmark. Each point is listed below and none of them is a forecast or a recommendation.

• Price action: the stock rose 8.42% from the previous close and was at its day high of Rs 2,097.00.
• Valuation: the P/E ratio of 41.43 is above the benchmark median of 30.74.
• Returns: return on equity of 18.78% and return on capital employed of 19.16% are above the industry medians.
• Book value: Rs 393.57 per share against earnings per share of Rs 46.68.
• Peers: the company sits in the middle of the five peers compared on P/E and P/B.

About Beta Drugs

Beta Drugs Ltd. trades under the symbol BETA and is classified in the Healthcare sector and the Pharmaceuticals and Drugs industry in Univest's company data. The market capitalisation behind Beta Drugs Share Price is Rs 2,199.67 crore. The industry benchmark used on Univest covers 199 companies, so Beta Drugs is placed among a broad group of listed names of very different sizes. Further company details, such as segments or revenue mix, are not part of today's update.

Frequently Asked Questions

What is the Beta Drugs share price today?

Ans. Beta Drugs Share Price stood at Rs 2,097.00 as of 12:37 PM IST on 28 October 2026, up Rs 162.80 or 8.42% from the previous close of Rs 1,934.20, according to latest Univest data.

Why is Beta Drugs stock rising today?

Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. The stock is up 8.42% from a previous close of Rs 1,934.20 and is trading at its day high of Rs 2,097.00.

What is the market capitalisation of Beta Drugs?

Ans. Beta Drugs Ltd. has a market capitalisation of Rs 2,199.67 crore. In the same-industry benchmark of 199 companies, the median market capitalisation is Rs 696.43 crore and the average is Rs 13,492.66 crore.

What is the P/E ratio of Beta Drugs?

Ans. The P/E ratio of Beta Drugs is 41.43, above the same-industry median of 30.74 and below the average of 43.30. The P/B ratio is 4.91, compared with a benchmark median of 2.71.

What are the ROE and ROCE of Beta Drugs?

Ans. Beta Drugs reports a return on equity of 18.78% and a return on capital employed of 19.16%. The industry medians are 11.23% for return on equity and 13.17% for return on capital employed.

What are the EPS, book value and dividend yield of Beta Drugs?

Ans. Earnings per share is Rs 46.68 and book value per share is Rs 393.57. The dividend yield is 0%, which means the latest Univest figures show no historical payout relative to the current price.

What was the day range of Beta Drugs Share Price today?

Ans. Beta Drugs Share Price opened at Rs 1,955.00, touched a low of Rs 1,903.80 and reached a high of Rs 2,097.00. The previous close was Rs 1,934.20, and the stock is trading at the day high.

How does Beta Drugs compare with its peers?

Ans. Among five listed peers, Beta Drugs has a P/E ratio of 41.43, above Sun Pharmaceutical Industries and Zydus Lifesciences and below Torrent Pharmaceuticals, Divi's Laboratories and Laurus Labs. Its market capitalisation is the smallest of the group.

Track Beta Drugs Share Price on Univest

Use Beta Drugs Ltd. (BETA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest lets users track the live share price, fundamental ratios, 52-week levels and market insights for Beta Drugs Ltd. in one place. Following Beta Drugs Share Price Live on Univest alongside the P/E ratio, P/B ratio, return on equity and peer figures gives a fuller picture than the price move alone, and the page updates through the trading day.